Aardvark Therapeutics, Inc. (AARD)
$4.76+1.06%Close
SELLCRISIS · day 30
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $104M
- Beta
- 3.81
- P/E (TTM)
- -1.57
- Short % float
- 4.35%
- Days to cover
- 5.3
- SI change
- +11.6%
- 1W
- -4.61%
- 1M
- -4.99%
- vs SPY 1W
- -5.77%
- vs SPY 1M
- -7.98%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AARD?
- LOPJLB’s latest quantitative signal on Aardvark Therapeutics, Inc. Common Stock (AARD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AARD in?
- Aardvark Therapeutics, Inc. Common Stock (AARD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Aardvark Therapeutics, Inc. Common Stock (AARD) do?
- Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It f…